Congenital Patterned Leukodermas

No Results

No Results

processing….

The following congenital hypopigmentary diseases result from a failure of pigment cells (melanocytes) in the skin, eyes, and/or ears to become completely or partially established in their target sites during embryogenesis:

Waardenburg syndrome (types I, II, and III)

Apert syndrome

Pfeiffer syndrome

Jackson-Weiss syndrome

Crouzon syndrome

Waardenburg syndrome type IV (Hirschsprung syndrome)

Piebaldism

Patients with these congenital patterned leukodermas may also present with extrapigmentary findings consisting of megacolon and musculoskeletal defects of the face and upper trunk.

The unifying abnormality of these congenital patterned leukodermas is a complete or partial absence of melanocytes in the skin and hair. Mutations in genes that regulate the multistep process of commitment of neural crest cells to a differentiated cell type (primarily the melanocyte) are the basis for these diseases. These mutations result in a failure of melanocytes to reach their normal destinations in developing skin, hair, eyes, and ears during embryogenesis. ^{[1, 2, 3, 4, 5, 6, 7]}

The causes of these congenital patterned leukodermas are mutations in specific genes. ^{[5, 8]}

Type I and type III Waardenburg syndromes result from mutations in the PAX3 gene, ^[9] which maps to band 2q35-q37.3. The syndrome is inherited as an autosomal dominant trait. The PAX3 gene encodes a transcription factor with a paired box domain, an octapeptide domain, and a homeobox domain essential for survival of melanocytes during development. The genes up-regulated by this transcription factor have not been identified; however, the PAX3 gene product can bind to the promoter of the MITF gene. ^{[6, 10, 11, 12, 13]}

Type II Waardenburg syndrome results from mutations in the microphthalmia transcription factor (MITF) gene, ^[14] which maps to band 3p12. The syndrome is inherited as an autosomal dominant trait. The MITF gene encodes a transcription factor containing a basic-helix-loop-helix-leucine zipper. The genes up-regulated by this transcription factor during embryogenesis have not been identified. ^[15]

Type IV Waardenburg syndrome (Hirschsprung syndrome) results from mutations in either (1) the SOX10 gene, which maps to band 22q13, or (2) the EDN3 gene, which maps to band 20q13.2-q13.3. The SOX10 gene encodes a member of the high-mobility group-domain Sox family of transcription factors that regulate neural crest development. The genes up-regulated by this transcription factor during embryogenesis have not been identified; however, the SOX10 gene product can bind to the promoter of the MITF gene. The EDN3 gene encodes a ligand called endothelin-3 for the endothelin-B receptor. ^{[10, 11, 16, 17]}

Apert, Pfeiffer, Jackson-Weiss, and Crouzon syndromes result from mutations in the fibroblast growth factor receptor-2 (FGFR2) gene, which maps to band 10q25-q26. These syndromes are inherited as autosomal dominant traits. The FGFR2 gene encodes a tyrosine kinase receptor with 3 immunoglobulin domains, a signal sequence, an acidic region in the extracellular ligand binding site, and 2 tyrosine kinase domains localized intracellularly. Some patients with Pfeiffer syndrome have demonstrated mutations in the fibroblast growth factor receptor-1 (FGFR1) gene, which maps to band 8p11.2-12. ^{[18, 19]}

Hirschsprung syndrome type 2 results from mutations in the endothelin-B receptor (EDNRB) gene, which maps to band 13q22. This syndrome is inherited as an autosomal recessive trait. The EDNRB gene encodes a G protein–coupled plasma membrane receptor with 7 transmembrane domains and 2 autophosphorylation sites.

Piebaldism results from mutations in the c-KIT gene, which maps to band 4q12. This syndrome is inherited as an autosomal dominant trait. The KIT gene encodes a plasma membrane receptor with a ligand-binding domain containing 5 immunoglobulinlike regions and 2 tyrosine kinase domains in the cytoplasm. Specific mutations of c-KIT correlate with the severity (ie, extent) of the cutaneous hypopigmentation. ^{[10, 20, 21, 22]} According to Yang et al, deletion of the SNAI2 gene causes human piebaldism. ^[7]

The approximate prevalences of the listed congenital patterned leukodermas are as follows:

Waardenburg syndrome (types I, II, and III) – 1 case per 15,000 population

Apert syndrome – 1 case per 65,000 population

Pfeiffer syndrome – Unknown (rare)

Jackson-Weiss syndrome – Unknown (rare)

Crouzon syndrome – 1 case per 25,000 population

Waardenburg syndrome type IV (Hirschsprung syndrome) – 1 case per 5000 population

Piebaldism – Unknown (rare)

All races appear to be equally affected by the associated mutations in congenital patterned leukodermas.

The prevalence of these congenital patterned leukodermas is equal for males and females.

All of these congenital patterned leukodermas are present at birth.

In the congenital patterned leukodermas, an absence of protective pigment in the skin results in increased sensitivity to solar irradiation. Affected individuals may be at increased risk of developing skin cancers. Sensorineural deafness can be extensive in patients with Waardenburg syndromes and Hirschsprung syndrome but is usually minimal or absent in those with Apert, Pfeiffer, Jackson-Weiss, or Crouzon syndromes. Persons with piebaldism only rarely have sensorineural deafness. Visual acuity does not appear to be impaired in any of the syndromes.

Boissy RE. Melanosome transfer to and translocation in the keratinocyte. Exp Dermatol. 2003. 12 Suppl 2:5-12. [Medline].

Boissy RE, Nordlund JJ. Molecular basis of congenital hypopigmentary disorders in humans: a review. Pigment Cell Res. 1997 Feb-Apr. 10(1-2):12-24. [Medline].

Pingault V, Ente D, Dastot-Le Moal F, Goossens M, Marlin S, Bondurand N. Review and update of mutations causing Waardenburg syndrome. Hum Mutat. 2010 Apr. 31(4):391-406. [Medline].

Samatha Y, Vardhan TH, Kiran AR, Sankar AJ, Ramakrishna B. Familial Crouzon syndrome. Contemp Clin Dent. 2010 Oct. 1(4):277-80. [Medline]. [Full Text].

Tomita Y, Suzuki T. Genetics of pigmentary disorders. Am J Med Genet C Semin Med Genet. 2004 Nov 15. 131C(1):75-81. [Medline].

Drozniewska M, Haus O. PAX3 gene deletion detected by microarray analysis in a girl with hearing loss. Mol Cytogenet. 2014. 7:30. [Medline]. [Full Text].

Yang YJ, Zhao R, He XY, Li LP, Chen W, Wang KW, et al. SNAI2 mutation causes human piebaldism. Am J Med Genet A. 2014 Mar. 164A(3):855-7. [Medline].

Bocángel MAP, Melo US, Alves LU, Pardono E, Lourenço NCV, Marcolino HVC, et al. Waardenburg syndrome: Novel mutations in a large Brazilian sample. Eur J Med Genet. 2018 Jan 31. [Medline].

Trabelsi M, Nouira M, Maazoul F, Kraoua L, Meddeb R, Ouertani I, et al. Novel PAX3 mutations causing Waardenburg syndrome type 1 in Tunisian patients. Int J Pediatr Otorhinolaryngol. 2017 Dec. 103:14-19. [Medline].

Dessinioti C, Stratigos AJ, Rigopoulos D, Katsambas AD. A review of genetic disorders of hypopigmentation: lessons learned from the biology of melanocytes. Exp Dermatol. 2009 Sep. 18(9):741-9. [Medline].

Hornyak TJ. The developmental biology of melanocytes and its application to understanding human congenital disorders of pigmentation. Adv Dermatol. 2006. 22:201-18. [Medline].

Tachibana M. A cascade of genes related to Waardenburg syndrome. J Investig Dermatol Symp Proc. 1999 Sep. 4(2):126-9. [Medline].

Tassabehji M, Read AP, Newton VE, et al. Waardenburg’s syndrome patients have mutations in the human homologue of the Pax-3 paired box gene. Nature. 1992 Feb 13. 355(6361):635-6. [Medline].

Wang XP, Liu YL, Mei LY, He CF, Niu ZJ, Sun J, et al. Wnt signaling pathway involvement in genotypic and phenotypic variations in Waardenburg syndrome type 2 with MITF mutations. J Hum Genet. 2018 Mar 12. [Medline].

Tassabehji M, Newton VE, Read AP. Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene. Nat Genet. 1994 Nov. 8(3):251-5. [Medline].

Mollaaghababa R, Pavan WJ. The importance of having your SOX on: role of SOX10 in the development of neural crest-derived melanocytes and glia. Oncogene. 2003 May 19. 22(20):3024-34. [Medline].

Moore SW. The contribution of associated congenital anomalies in understanding Hirschsprung’s disease. Pediatr Surg Int. 2006 Apr. 22(4):305-15. [Medline].

Park WJ, Meyers GA, Li X, et al. Novel FGFR2 mutations in Crouzon and Jackson-Weiss syndromes show allelic heterogeneity and phenotypic variability. Hum Mol Genet. 1995 Jul. 4(7):1229-33. [Medline].

Park WJ, Theda C, Maestri NE, et al. Analysis of phenotypic features and FGFR2 mutations in Apert syndrome. Am J Hum Genet. 1995 Aug. 57(2):321-8. [Medline].

Giebel LB, Spritz RA. Mutation of the KIT (mast/stem cell growth factor receptor) protooncogene in human piebaldism. Proc Natl Acad Sci U S A. 1991 Oct 1. 88(19):8696-9. [Medline]. [Full Text].

Thomas I, Kihiczak GG, Fox MD, Janniger CK, Schwartz RA. Piebaldism: an update. Int J Dermatol. 2004 Oct. 43(10):716-9. [Medline].

Hemati P, du Souich C, Boerkoel CF. 4q12-4q21.21 deletion genotype-phenotype correlation and the absence of piebaldism in presence of KIT haploinsufficiency. Am J Med Genet A. 2015 Jan. 167A (1):231-7. [Medline].

Sólia-Nasser L, de Aquino SN, Paranaíba LM, Gomes A, Dos-Santos-Neto P, Coletta RD, et al. Waardenburg syndrome type I: Dental phenotypes and genetic analysis of an extended family. Med Oral Patol Oral Cir Bucal. 2016 May 1. 21 (3):e321-7. [Medline].

Shields CL, Nickerson SJ, Al-Dahmash S, Shields JA. Waardenburg syndrome: iris and choroidal hypopigmentation: findings on anterior and posterior segment imaging. JAMA Ophthalmol. 2013 Sep. 131(9):1167-73. [Medline].

Kontorinis G, Goetz F, Lanfermann H, Luytenski S, Giesemann AM. Inner ear anatomy in Waardenburg syndrome: Radiological assessment and comparison with normative data. Int J Pediatr Otorhinolaryngol. 2014 Aug. 78(8):1320-6. [Medline].

Harvey I, Brown S, Ayres O, Proudman T. The apert hand-angiographic planning of a single-stage, 5-digit release for all classes of deformity. J Hand Surg Am. 2012 Jan. 37(1):152-8. [Medline].

Soanca A, Dudea D, Gocan H, Roman A, Culic B. Oral manifestations in Apert syndrome: case presentation and a brief review of the literature. Rom J Morphol Embryol. 2010. 51(3):581-4. [Medline].

Ettinger N, Williams M, Phillips JA 3rd. Variable expressivity and clinical heterogeneity can complicate the diagnosis and management of Pfeiffer syndrome. J Craniofac Surg. 2013 Sep. 24(5):1829-32. [Medline].

Raymond E Boissy, PhD Director of Basic Science Research, Professor, Departments of Dermatology and Cell Biology, University of Cincinnati College of Medicine

Raymond E Boissy, PhD is a member of the following medical societies: Sigma Xi

Disclosure: Nothing to disclose.

Steven Hoath, MD Director of Skin Sciences Institute, Professor of Pediatrics, Department of Pediatrics, University of Cincinnati College of Medicine

Disclosure: Nothing to disclose.

Michael J Wells, MD, FAAD Dermatologic/Mohs Surgeon, The Surgery Center at Plano Dermatology

Michael J Wells, MD, FAAD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, Texas Medical Association

Disclosure: Nothing to disclose.

Van Perry, MD Assistant Professor, Department of Medicine, Division of Dermatology, University of Texas School of Medicine at San Antonio

Van Perry, MD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

William D James, MD Paul R Gross Professor of Dermatology, Vice-Chairman, Residency Program Director, Department of Dermatology, University of Pennsylvania School of Medicine

William D James, MD is a member of the following medical societies: American Academy of Dermatology, Society for Investigative Dermatology

Disclosure: Received income in an amount equal to or greater than $250 from: Elsevier; WebMD.

Kathryn Schwarzenberger, MD Associate Professor of Medicine, Division of Dermatology, University of Vermont College of Medicine; Consulting Staff, Division of Dermatology, Fletcher Allen Health Care

Kathryn Schwarzenberger, MD is a member of the following medical societies: Women’s Dermatologic Society, American Contact Dermatitis Society, Medical Dermatology Society, Dermatology Foundation, Alpha Omega Alpha, American Academy of Dermatology

Disclosure: Nothing to disclose.

Congenital Patterned Leukodermas

Research & References of Congenital Patterned Leukodermas|A&C Accounting And Tax Services
Source

Share on Facebook

Tweet

Follow us